Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of two doses of VI-0521
compared to placebo in treatment of obesity in an adult population with BMI ≥ 35.